hum0195 Release Note
| Research ID | Release Date | Type of Data |
|---|---|---|
| hum0195.v3 | 2022/03/18 | NGS (Exome) |
| hum0195.v2 | 2022/03/02 | NGS (Exome, Target Capture, RNA-seq) |
| hum0195.v1 | 2021/03/26 | NGS (WGS, Exome, RNA-seq) |
hum0195.v3
DNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of 1 patients with gastric cancer were used for whole exome sequencing (fastq files).
hum0195.v2
DNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of 36 patients with gastric cancer and 3 patients with gastric submucosal tumor patients were used for whole exome sequencing and target capture sequencing analyses (fastq files).
Total RNAs extracted from non-tumor tissues (only gland duct) of 5 IM samples and 3 non-IM samples were used for RNA sequencing analysis (fastq files).
hum0195.v1
- DNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of 5 nodule-in-nodule hepatocellular carcinoma patients were used for whole genome sequencing analyses (fastq files).
- DNAs/RNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of 20 liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication, 3 hepatitis C virus positive cirrhosis and hepatocellular carcinoma and 2 hepatitis C virus negative hepatocellular carcinoma patients were used for whole exome sequencing and RNA sequencing analysis (fastq files).
Note：
